Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting

• Asıl Yazarlar: Niamh Carey (Yazar), Joy Leahy (Yazar), Lea Trela-Larsen (Yazar), Laura Mc Cullagh (Yazar), Michael Barry (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

ABSTRACTBackground The evidence base of tisagenlecleucel is uncertain.Objective To evaluate the cost-effectiveness of tisagenlecleucel. To conduct expected value of perfect information (EVPI) and partial EVPI (EVPPI) analyses.Study Design A three-state partitioned survival model. A short-term decisi...